GL1X · GenesisL1 explorer

MolNFT v1 · #91326 · protein

Human P38 alpha mitogen-activated kinase in complex with SB239063

4FA2 · Mitogen-activated protein kinase 14: “Human P38 alpha mitogen-activated kinase in complex with SB239063”. X-ray diffraction, 2 ligands (GG5, SB0), 6 pockets (best druggability 0.67). MolNFT v1 #91326 on GenesisL1: 3D structure…

PDB
4FA2
Type
protein
Length
339 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 14
EC
2.7.11.24
UniProt
Q16539
Ligands
GG5, SB0
Pockets
6 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 14 (EC 2.7.11.24)protein33941% helix, 16% strandQ16539

Ligands and binding sites

  • GG5 · 4-[3-(4-fluorophenyl)-1H-pyrazol-4-yl]pyridine · ligand · chains A
  • SB0 · trans-4-[4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)-1H-imidazol-1-yl]cyclohexanol · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A
  • BME · Beta-mercaptoethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12540.670.8330SB0, EDO
21130.660.8919GG5
32660.530.7644empty
41640.520.7928empty
5520.270.7414empty

Modifications

Observed in the structure: 1 covalent (additive adduct).

Compared structures

  • 4FA2 · Human P38 alpha Mitogen-Activated Kinase In Complex With SB239063 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.